05 January 2021 : Original article
Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model
Li Lei12BCDEF, Qing Li1BCDF, Shuhong Xu2BCF, Mingyang Tian2BCD, Xinghui Zheng1BCD, Yunxia Bi1BF, Bo Huang1ABDEG*DOI: 10.12659/AOT.924461
Ann Transplant 2021; 26:e924461
Figure 1 Peptide injections decrease EV71 particle levels in muscle, small intestines, and brain tissues. (A) ELISA immunogenicity analysis for the synthesized peptides (1–20). Lanes 1–20 represent the synthesized peptides. (B) cDNA bands for EV71 distribution in tissues. Lanes 1, 2, and 3 show the level of EV71 virus in skeletal muscle, small intestines, and brain tissues, respectively. (C) Quantification and statistical analysis of relative mRNA expression of the EV71 virus by a semi-quantitative RT-PCR assay. ** P<0.01 vs. the Newborn EV71 group. EV71 – enterovirus 71.






